Effect of a new functional CYP3A4 polymorphism on tacrolimus dose requirement and trough blood levels in stable renal transplant patients

被引：0
|
作者：
Elens, L. [1 ]
van Schaik, R. [1 ]
Panin, N. [2 ]
De Meyer, M. [3 ]
Wallemacq, P. [2 ]
Lison, D. [2 ]
Mourad, M. [3 ]
Haufroid, V [2 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium
[3] Clin Univ St Luc, Kidney & Pancreas Transplantat Unit, B-1200 Brussels, Belgium
来源：
THERAPEUTIC DRUG MONITORING | 2011年 / 33卷 / 04期
关键词：
CYP3A4; CYP3A5; tacrolimus; kidney transplantation; pharmacogenetics; pharmacokinetics; single nucleotide polymorphism;
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：507 / 507
页数：1
相关论文
共 50 条
  • [21] Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipients
    Dina Chen
    Huijie Lu
    Weiguo Sui
    Liqing Li
    Jian Xu
    Tengfei Yang
    Siyao Yang
    Ping Zheng
    Yan Chen
    Jiejing Chen
    Wen Xue
    Qingping Li
    Que Zheng
    Demei Ye
    Wolfgang Sadee
    Danxin Wang
    Wanying Qian
    Liusheng Lai
    Chuanjiang Li
    Liang Li
    The Pharmacogenomics Journal, 2021, 21 : 376 - 389
  • [22] Influence of CYP3A5 polymorphism on tacrolimus blood concentrations in renal transplant patients
    Xin-min Nie
    Rong Gui
    Hong-shan Zhao
    Da-long Ma
    Deng-qing Li
    Hong Yuan
    Zu-fa Huang
    Journal of Central South University of Technology, 2005, 12 : 310 - 312
  • [23] In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients
    de Jonge, H.
    de Loor, H.
    Verbeke, K.
    Vanrenterghem, Y.
    Kuypers, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (03) : 366 - 375
  • [24] Influence of CYP3A5 polymorphism on tacrolimus blood concentrations in renal transplant patients
    Nie, XM
    Gui, R
    Zhao, HS
    Ma, DL
    Li, DQ
    Yuan, H
    Huang, ZF
    JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY, 2005, 12 (Suppl 1): : 310 - 312
  • [25] Combination of CYP3A4 measurement in vivo and genetic stratification for P-glycoprotein explains 71% of dose/weight normalized tacrolimus trough levels in renal transplant recipients
    Lemahieu, WPD
    Maes, BD
    Pierik, M
    Verbeke, K
    Vanrenterghem, YF
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V163 - V163
  • [26] EFFECT OF CYP3A5, CYP3A4, POR AND ABCB1 POLYMORPHISMS ON TACROLIMUS METABOLISM IN RENAL TRANSPLANT PATIENTS
    Chong, Winnie
    Hamilton-Jones, Siobhan
    Kim, Jon Jin
    Navarrete, Cristina V.
    Key, Tim
    Howell, Martin W.
    HLA, 2020, 95 (04) : 316 - 316
  • [27] Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients
    Miura, Masatomo
    Satoh, Shigeru
    Kagaya, Hideaki
    Saito, Mitsuru
    Numakura, Kazuyuki
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    PHARMACOGENOMICS, 2011, 12 (07) : 977 - 984
  • [28] Effect of CYP3A4 and PPARA polymorphism on concentration-to-dose ratio and adverse effects of tacrolimus in Pakistani liver transplant recipients
    Azam, Fahad
    Khan, Moosa
    Shaheen, Abida
    Bhatti, AbuBakar Hafeez
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (07) : 1893 - 1898
  • [29] CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients
    Li, Dan-ying
    Teng, Rui-chen
    Zhu, Huai-jun
    Fang, Yun
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (06) : 466 - 474
  • [30] THE NEW CYP3A4 INTRON 6 POLYMORPHISM (CYP3A4*22) IS SIGNIFICANTLY ASSOCIATED WITH DECREASED TACROLIMUS METABOLISM.
    van Schaik, R. H.
    Elens, L.
    Bouamar, R.
    Hesselink, D. A.
    Haufroid, V.
    van Gelder, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S107 - S107
12345